Karoline Leavitt's Vanity Fair photos raise concern about cosmetic injections during pregnancy

Karoline Leavitt announced she is expecting a baby girl due in May 2026. Photos from a recent Vanity Fair shoot prompted some medical experts to say elective cosmetic injectables are usually advised to be postponed during pregnancy because safety data are limited.

Karoline Leavitt, the White House press secretary, recently announced she is expecting a second child due in May 2026. Close-up images from a Vanity Fair photoshoot drew attention for the appearance of her lips and small red marks. Several medical experts were reported as expressing concern, noting there is limited evidence on the safety of elective cosmetic injectables during pregnancy. Neither Leavitt nor the White House has confirmed whether any cosmetic procedures took place. What was reported: - Leavitt confirmed her second pregnancy and said the baby is due in May 2026; she and her husband have a young son. - Photos from a November Vanity Fair shoot showed a close-up of her lips and small red marks that some viewers described as possible injection sites. - Medical professionals were reported as advising that elective cosmetic injectables are generally recommended to be postponed until after delivery and nursing because data on safety in pregnancy are limited. - A dermatologist affiliated with an academic medical center noted that pregnancy can change immune and inflammatory responses, which may affect how side effects appear. - There has been discussion on social media, and no official confirmation has been provided regarding any procedures. Summary: The reports have prompted public discussion about cosmetic procedures and pregnancy safety, with experts noting uncertainty in the available evidence. Official confirmation about whether Leavitt received injectables is undetermined at this time.